U.S. Software Stock News

Syndax Pharmaceuticals (SNDX) stock is back in focus after the company reported Phase 1/2 SAVE trial data for its all-oral Revuforj-based regimen in heavily pretreated acute myeloid leukemia patients with high-risk mutations. See our latest analysis for Syndax Pharmaceuticals. The SAVE trial update appears to have given the stock a short-term lift, with a 1-day share price return of 1.9% and 7-day share price return of 5.3%. However, the 90-day share price return is down 24.1%, while the...

Recent analyst activity around Karooooo (KARO) has focused on a series of upward earnings estimate revisions and an improved ranking. This has prompted investors to reassess how the stock’s recent performance aligns with these expectations. See our latest analysis for Karooooo. Karooooo’s recent 3.8% 1 day share price return at US$47.27 and 5.8% year to date share price return sit against a very large 3 year total shareholder return of about 12x, suggesting investors are weighing earlier...

Arcos Dorados Holdings (ARCO) is back in focus after reporting first quarter 2026 results that featured 13% revenue growth, 16% system-wide comparable sales growth, and record adjusted EBITDA, with Brazil margins a clear highlight for investors. See our latest analysis for Arcos Dorados Holdings. The recent first quarter earnings news follows a strong run in the stock, with an 8.61% 1 month share price return, 13.35% 3 month share price return and 21.12% year to date share price return. The 1...

Analyst scrutiny and legal questions keep Universal Health Services in focus Universal Health Services (UHS) is back in the spotlight as fresh analyst commentary on growth and valuation collides with ongoing regulatory and legal pressure tied to patient safety investigations in multiple states. See our latest analysis for Universal Health Services. At a share price of US$146.42, UHS has seen its 1-month share price return fall 13.18% and its year to date share price return fall 33.41%, while...

H2O America recently announced that executive Kristen Johnson will depart the company without cause, effective 3 July 2026, with severance provided under her employment agreement. Alongside this leadership change, H2O America has extended its 58-year dividend growth streak with a 4.8% quarterly increase and reaffirmed its 2026 earnings guidance. Next, we’ll examine how Johnson’s departure and the continued dividend growth track record may influence H2O America’s broader investment...

BeOne Medicines (NasdaqGS:ONC) is back in focus after EHA 2026 data for BRUKINSA, tacabrutideg and the BRUKINSA plus sonrotoclax regimen in B-cell malignancies, highlighting long-term efficacy signals and detailed real-world evidence. See our latest analysis for BeOne Medicines. Despite the strong flow of clinical and index news, BeOne Medicines’ shares have eased, with the 30-day share price return down 9.82% and year-to-date share price return down 14.96%, while the 3-year total shareholder...

In early June 2026, Signet Jewelers launched a new US$50 million accelerated share repurchase program with Goldman Sachs, alongside updated fiscal 2027 sales guidance, fresh second-quarter forecasts, an affirmed US$0.35 quarterly dividend, and first-quarter results showing slightly higher revenue and marginally lower net income year over year. The combination of continued buybacks, including nearly 24.41 million shares repurchased since 2017, and ongoing cash dividends highlights Signet’s...

Recently, a jury found Ameris Bancorp liable in a wrongful termination case with a total verdict of about US$79.95 million, including roughly US$16.53 million in economic and non-economic damages plus statutory penalties and about US$62.90 million in punitive damages. The bank plans to appeal the decision and is assessing how such a large punitive award could affect its financial results, overall condition, and liquidity. We’ll now examine how this sizable wrongful termination verdict and...

Setting the stage for Air Products and Chemicals stock Air Products and Chemicals (APD) has attracted attention after recent share moves, with the stock closing at $281.62. Investors are weighing this level against the company’s size, profitability, and multi regional revenue base. See our latest analysis for Air Products and Chemicals. Recent price action has been mixed, with the 1 day share price return of 1.26% set against a 30 day share price return down 4.66%. The 5 year total...

UFP Technologies (UFPT) is back on investors’ radar after a cluster of leadership changes, including Mitchell C. Rock becoming Chief Executive Officer and Ryan Stafford taking the General Counsel and Senior Vice President of Human Resources roles. See our latest analysis for UFP Technologies. The leadership reshuffle has landed alongside a rebound in momentum, with the share price up 9.81% over 30 days and 15.72% over 90 days. The 1-year total shareholder return of 0.83% trails the very large...

NWPX Infrastructure (NWPX) is in focus after completing the first field installation of its patent-pending Permalok Radial Bending Joint during an emergency wastewater microtunneling project beneath Pleasure Bay in New Jersey. See our latest analysis for NWPX Infrastructure. The Permalok news lands at a time when momentum in NWPX Infrastructure’s stock has been building, with a 7 day share price return of 9.42% and a 90 day share price return of 77.92%, contributing to a very large 1 year...

Earlier this month, UDR Inc. announced it will shift from quarterly to monthly dividend payments starting in July and expanded its share repurchase authorization by US$25.00 million as part of a broader capital return plan. These changes in how UDR returns cash to shareholders, alongside recent insider selling by its CEO, highlight evolving signals about management’s confidence and capital priorities. Next, we’ll examine how UDR’s move to monthly dividends could influence its existing...

Tripadvisor’s recent share move in focus Tripadvisor (TRIP) has drawn attention after a recent rebound in the stock, with a gain over the past month and past 3 months standing against weaker longer term returns and a modest market value. For readers tracking travel and online platform stocks, Tripadvisor now sits around a share price of $12.41 and a market cap of about $1.4b, with revenue of $1,875.2m and net income of $18.6m. See our latest analysis for Tripadvisor. The recent 31.2% 1 month...

Ionis Pharmaceuticals (IONS) has put fresh clinical data for its triglyceride drug candidate olezarsen in front of investors, with new 24 month results from the CORE OLE study presented at the National Lipid Association Scientific Sessions. See our latest analysis for Ionis Pharmaceuticals. The recent olezarsen data come as Ionis shares trade at US$73.28, with the stock down over the year to date but supported by a very large 1 year total shareholder return. This points to strong longer term...

Omnicell stock snapshot after recent performance moves Omnicell (OMCL) has drawn investor attention after a mixed stretch, with the stock roughly flat over the past day, down about 12% over the past month, and up around 10% in the past 3 months. See our latest analysis for Omnicell. Looking beyond the recent pullback, Omnicell’s 1 year total shareholder return of 29.33% contrasts with the weaker year to date share price return of 16.19%. This suggests that earlier momentum has cooled as...

Earlier this quarter, Accel Entertainment reported quarterly revenue growth of 8.5% year on year, surpassing analyst expectations even as operating income trends were mixed. This revenue surprise stands out because it reflects resilience in Accel’s local gaming footprint while many consumer discretionary peers also beat sales forecasts. Next, we’ll examine how this stronger-than-expected revenue performance may influence Accel Entertainment’s existing investment narrative and growth...

MBX Biosciences recently reported full 12-week Phase 2 Avail trial results and one-year open-label extension data for once-weekly canvuparatide in adults with chronic hypoparathyroidism, showing higher responder rates versus placebo, sustained calcium control, kidney and bone effects consistent with PTH replacement, and a generally well-tolerated safety profile. An important nuance for investors is that pharmacokinetic data supported genuinely once-weekly dosing, with stable systemic...

In recent days, Comfort Systems USA has attracted attention as multiple research firms initiated positive coverage while the company reported continued strong demand from data center and AI-related construction, backed by a record project pipeline and consistent earnings outperformance. An interesting aspect of this development is that the upbeat analyst views arrived alongside a period of heavy insider share selling and concerns about an increasingly rich valuation, highlighting a tension...

Extra Space Storage (EXR), a large US self-storage REIT, has drawn investor attention after recent share price moves, with the stock closing at US$150.60 and posting mixed return figures over the past year and past 3 months. See our latest analysis for Extra Space Storage. Recent share price gains, including a 10.01% 1 month share price return and 14.99% year to date share price return, suggest improving momentum. Longer term total shareholder returns, such as 16.92% over three years, show a...

Recent trading snapshot and context Protagonist Therapeutics (PTGX) has drawn investor attention after recent share price moves, with the stock last closing at US$109.78 and posting gains over the past week, month and past 3 months. See our latest analysis for Protagonist Therapeutics. Looking beyond the latest move, Protagonist Therapeutics has shown strong momentum, with a 25.92% year to date share price return and a 94.75% total shareholder return over the past year. If you are tracking...

Monolithic Power Systems (MPWR) is back in focus after strong Q1 2026 results and a sharp pickup in enterprise data revenue tied to AI servers, along with higher guidance that sharpened attention on growth and valuation. See our latest analysis for Monolithic Power Systems. The recent pullback, with a 1-day share price return of 0.77% down to US$1,577.32, sits against a much stronger backdrop. This includes a 46.4% 90-day share price return and a 136.15% 1-year total shareholder return,...

Noble Corporation plc recently priced an upsized US$800 million offering of 6.250% Senior Notes due 2034, completed in the past, with plans to use the proceeds and cash on hand to redeem its higher-coupon 8.500% Senior Secured Second Lien Notes due 2030 and US$300 million of 8.000% Senior Notes due 2030. This refinancing move highlights Noble’s effort to lower interest costs and reshape its debt profile, potentially supporting future financial flexibility and cash flow. We’ll now examine how...

Earlier this month, Camtek Ltd. reported securing over US$105,000,000 in multi-system orders tied to AI applications from a tier-1 OSAT and an HBM customer, with deliveries scheduled for 2027. The scale and AI focus of these Hawk system orders underline how closely Camtek’s inspection and metrology tools are now aligned with high-bandwidth memory and advanced packaging demand. We’ll now examine how these AI-focused multi-system orders from leading semiconductor customers may influence...

Recent move in S&P Global stock S&P Global (SPGI) shares recently closed at US$418.91, leaving the stock down about 18% year to date and about 16% over the past year, despite positive annual revenue and net income growth. See our latest analysis for S&P Global. Over the past month, S&P Global has seen a 30 day share price return of 3.91%, but the year to date share price is still down 18.29%, and the 1 year total shareholder return is down 15.77%. This contrasts with the positive 3 year and 5...